Zura Bio Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Selling, General & Admin	20.59	18.64	3.47	0.89
Research & Development	42.71	44	23.69	0
Operating Expenses	63.3	62.64	27.16	0.89
Operating Income	-63.3	-62.64	-27.16	-0.89
Other Expense / Income	-4.78	-2.28	-1.42	-7.74
Pretax Income	-58.52	-60.36	-25.74	6.85
Net Income	-58.52	-60.36	-25.74	6.85
Preferred Dividends	1.66	8.88	6.65	0
Net Income Common	-60.18	-69.24	-32.39	6.85
Shares Outstanding (Basic)	47	33	0	11
Shares Outstanding (Diluted)	47	33	0	11
Shares Change	1220.83%	14392.36%	-97.95%	-
EPS (Basic)	-1.38	-2.09	-141.97	0.62
EPS (Diluted)	-1.38	-2.09	-141.97	0.61
Free Cash Flow	-16.79	-15.05	-1.2	-1.1
Free Cash Flow Per Share	-0.36	-0.46	-5.27	-0.10
EBITDA	-58.52	-60.36	-25.74	6.85
EBIT	-58.52	-60.36	-25.74	6.85

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).